Dr. Khalil Eldeeb

Associate Professor
Jerry M. Wallace School of Osteopathic Medicine
Office Location:
Tracey F. Smith Hall of Nursing and Health Sciences
Room 432
Mailing Address:
PO Box 4280
Buies Creek, NC 27506


Dr. Eldeeb received his Medical degree and his Master of Pharmacology from Al-Azhar University in Cairo Egypt. In 2011, Dr. Eldeeb completed his Ph.D. studies in pharmacology at the University of Nottingham, UK, studying the role of cannabinoid receptors in microglia functions. 

He completed postdoctoral fellowship at Wake Forest University School of Medicine among the first cohort of The Postdoctoral Research, Instruction, and Mentoring Experience (PRIME) scholarship where he continued his research on cannabinoid signaling in neuronal cells as well as taught and facilitated courses at both Winston-Salem State University (Doctor of Physical Therapy Program) and Wake Forest University Graduate School. 

Dr. Eldeeb research presentations were recognized and awarded the best poster communication prize at the 6th European Workshop on Cannabinoid Research (Ireland 2013) as well as the best postdoctoral poster prize at the 24th Annual International Cannabinoid Research Society (ICRS) Symposium on the Cannabinoids Research (Italy 2014). Dr. Eldeeb research findings were published in peer-reviewed and high impact journals such as Molecular Pharmacology, British Journal of Pharmacology, and Neuropsychopharmacology. 

Dr. Eldeeb current research investigating cannabinoid receptors and associated proteins is supported by a sub-award from an R01 grant from the National Institute on Drug Abuse (NIDA) in collaboration with Dr. Allyn Howlett at Wake Forest School of Medicine.

Besides serving on the school and University appointed committees, Dr. Eldeeb also serving in the National Board of Osteopathic Medical Examiners (NBOME) as National faculty for Pharmacology writing exam questions for different exam levels. 

The focus of Dr. Eldeeb career has been to serve as an outstanding educator and to develop a research program to advance our understanding of the role of the cannabinoid signaling system in different diseases.